Studie - Slimming Products - Germany

Slimming products continue to show growth due to the current health and wellness trend in Germany. The government is making the population aware of the side effects obesity can cause and is heavily promoting healthy eating and a more active lifestyle. A number of consumers continue to search for easier options to lose weight instead of constant healthy eating and exercise regimes.

Euromonitor International's Slimming Products Products in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: Meal Replacement Slimming, Other Slimming Products, Slimming Teas, Weight Loss Supplements

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Slimming Products in Germany

Euromonitor International

April 2010

List of Contents and Tables

Executive Summary

Expenditure on Consumer Health Slows Down Compared To Previous Years

OTC Obesity Drugs Enter Market

Main Brands Continue To Gain Importance

Distribution Channels Continue To Shift Slowly

Forecast Performance Expected To Remain Sluggish

Key Trends and Developments

Increased Obesity Rates Are Having A Positive Impact on Supplement Sales

Private Label Products Continue To Increase Market Share in Many Categories

Consumer Doubts Impact Sales of OTC Medicine

Increasing Trust in Homoeopathic Remedies Shifts Consumer Demand

European Court of Justice Stops Setting Up of Chemist/pharmacy Chains

Market Indicators

Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009

Table 2 Life Expectancy at Birth 2004-2009

Market Data

Table 3 Sales of Consumer Health by Sector: Value 2004-2009

Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009

Table 5 Consumer Health Company Shares by Value 2005-2009

Table 6 Consumer Health Brand Shares by Value 2006-2009

Table 7 Penetration of Private Label by Sector 2004-2009

Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009

Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009

Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014

Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine (florian)

Switches

Summary 1 OTC Healthcare Switches 2007-2009

Definitions

Sector and Subsector Definitions

Summary 2 Research Sources

Bad Heilbrunner Naturheilmittel GmbH & Co

Strategic Direction

Key Facts

Summary 3 Bad Heilbrunner Naturheilmittel GmbH & Co: Key Facts

Summary 4 Bad Heilbrunner Naturheilmittel GmbH & Co: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 5 Bad Heilbrunner Naturheilmittel GmbH & Co: Competitive Position 2009

Bayer Vital GmbH

Strategic Direction

Key Facts

Summary 6 Bayer Vital GmbH: Key Facts

Summary 7 Bayer Vital GmbH: Operational Indicators

Company Background

Production

Summary 8 Bayer Vital AG: Production Statistics 2009

Competitive Positioning

Summary 9 Bayer Vital GmbH: Competitive Position 2009

Beiersdorf AG

Strategic Direction

Key Facts

Summary 10 Beiersdorf AG: Key Facts

Summary 11 Beiersdorf AG: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 12 Beiersdorf AG: Competitive Position 2009

Boehringer Ingelheim Pharma GmbH & Co Kg

Strategic Direction

Key Facts

Summary 13 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts

Summary 14 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators

Company Background

Production

Summary 15 Boehringer Ingelheim Pharma GmbH & Co KG: Production Statistics 2009

Competitive Positioning

Summary 16 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2009

Mcm Klosterfrau Vertriebsgesellschaft Mbh

Strategic Direction

Key Facts

Summary 17 MCM Klosterfrau Vertriebsgesellschaft mbH: Key Facts

Summary 18 MCM Klosterfrau Vertriebsgesellschaft mbH: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 19 MCM Klosterfrau Vertriebsgesellschaft mbH: Competitive Position 2009

Medice GmbH & Co Kg

Strategic Direction

Key Facts

Summary 20 Medice GmbH & Co KG: Key Facts

Summary 21 Medice GmbH & Co KG: Operational Indicators

Company Background

Production

Summary 22 Medice GmbH & Co KG: Production Statistics 2009

Competitive Positioning

Summary 23 Medice GmbH & Co KG: Competitive Position 2009

Strategic Direction

Key Facts

Summary 24 Novartis Deutschland GmbH: Key Facts

Summary 25 Novartis Deutschland GmbH: Operational Indicators

Company Background

Production

Summary 26 Novartis Deutschland GmbH: Production Statistics 2009

Competitive Positioning

Summary 27 Novartis Deutschland GmbH: Competitive Position 2009

Ratiopharm GmbH & Co

Strategic Direction

Key Facts

Summary 28 Ratiopharm GmbH & Co: Key Facts

Summary 29 Ratiopharm GmbH & Co: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 30 Ratiopharm GmbH & Co: Competitive Position 2009

Stada Arzneimittel AG

Strategic Direction

Key Facts

Summary 31 STADA Arzneimittel AG: Key Facts

Summary 32 STADA Arzneimittel AG: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 33 STADA Arzneimittel AG: Competitive Position 2009

Headlines

Trends

Competitive Landscape

Prospects

Category Data

Table 12 Sales of Slimming Products by Subsector: Value 2004-2009

Table 13 Sales of Slimming Products by Subsector: % Value Growth 2004-2009

Table 14 Slimming Products Company Shares 2005-2009

Table 15 Slimming Products Brand Shares 2006-2009

Table 16 Forecast Sales of Slimming Products by Subsector: Value 2009-2014

Table 17 Forecast Sales of Slimming Products by Subsector: % Value Growth 2009-2014

• Database of Supermarkets and Other Grocery Stores in Thailand
• Innovations in Diabetes Management with Food and Drinks: Key ingredients, NPD, emerging business models and leading innovators
• Weight Management Trends & Behaviors: Beyond Dieting & Obesity
• Weight Management Trends & Behaviors: Beyond Dieting & Obesity
• The Future of Gluten-Free: Consumer Insight and Product Opportunities
• Slimming Products - Austria
• Slimming Products - France
• Slimming Products - Macedonia
• Slimming Products - Poland
• Slimming Products - Spain
• Slimming Products - United Arab Emirates
• Slimming Products - Algeria
• Slimming Products - Greece
• Slimming Products - India
• Slimming Products - Indonesia
• Slimming Products - Philippines
• Slimming Products - Portugal
• Slimming Products - Singapore
• Slimming Products - Turkey
• Slimming Products - USA